Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice

European Journal of Immunology

Volumn 44, Issue 11, 2014, Pages 3295-3306

  Schmid, Maximilian ^a   Zimara, Nicole ^a   Wege, Anja Kathrin ^b   Ritter, Uwe ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Arginase 1; Bone marrow; Inducible nitric oxide synthase; Leishmania major; Myeloid derived suppressor cells

Indexed keywords

CCR2 PROTEIN, MOUSE; CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; INDUCIBLE NITRIC OXIDE SYNTHASE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; NOS2 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; GENETICS; IMMUNOLOGY; LEISHMANIA MAJOR; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PARASITE LOAD; SKIN LEISHMANIASIS;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYELOID CELLS; NITRIC OXIDE SYNTHASE TYPE II; PARASITE LOAD; RECEPTORS, CCR2;

EID: 84916879405     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344335     Document Type: Article

References (59)

1. Stafford, J. L., Neumann, N. F. and Belosevic, M., Macrophage-mediated innate host defense against protozoan parasites. Crit. Rev. Microbiol. 2002. 28: 187-248.
2. Plüddemann, A., Mukhopadhyay, S. and Gordon, S., Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry. Immunol. Rev. 2011. 240: 11-24.
3. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
4. Schmid, M., Wege, A. K. and Ritter, U., Characteristics of "Tip-DCs and MDSCs" and their potential role in leishmaniasis. Front. Microbiol. 2012. 3: 74.
5. Horst, A. K., Bickert, T., Brewig, N., Ludewig, P., van Rooijen, N., Schumacher, U., Beauchemin, N. et al., CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood 2009. 113: 6726-6736.
6. Ritter, U., Frischknecht, F. and van Zandbergen, G., Are neutrophils important host cells for Leishmania parasites? Trends Parasitol. 2009. 25: 505-510.
7. Srivastava, M. K., Zhu, L., Harris-White, M., Kar, U., Huang, M., Johnson, M. F., Lee, J. M. et al., Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One 2012. 7: e40677.
8. Tartour, E., Pere, H., Maillere, B., Terme, M., Merillon, N., Taieb, J., Sandoval, F. et al., Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev. 2011. 30: 83-95.
9. Sacks, D. and Noben-Trauth, N., The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002. 2: 845-858.
10. Alexander, J. and Bryson, K., T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol. Lett. 2005. 99: 17-23.
11. Liese, J., Schleicher, U. and Bogdan, C., The innate immune response against Leishmania parasites. Immunobiology 2008. 213: 377-387.
12. Nathan, C., Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 2006. 6: 173-182.
13. Peters, N. C., Egen, J. G., Secundino, N., Debrabant, A., Kimblin, N., Kamhawi, S., Lawyer, P. et al., In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 2008. 321: 970-974.
14. Murray, H. W., Xiang, Z. and Ma, X., Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase. Am. J. Trop. Med. Hyg. 2006. 74: 1013-1015.
15. Murray, I. A., Daniels, I., Coupland, K., Smith, J. A. and Long, R. G., Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2002. 283: G319-G326.
16. Scott, P., Natovitz, P., Coffman, R. L., Pearce, E. and Sher, A., Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 1988. 168: 1675-1684.
17. Rogers, K. A., DeKrey, G. K., Mbow, M. L., Gillespie, R. D., Brodskyn, C. I. and Titus, R. G., Type 1 and type 2 responses to Leishmania major. FEMS Microbiol. Lett. 2002. 209: 1-7.
18. Steinbrink, K., Schönlau, F., Rescher, U., Henseleit, U., Vogel, T., Sorg, C. and Sunderkötter, C., Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells. Immunobiology 2000. 202: 442-459.
19. Shi, C. and Pamer, E. G., Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011. 11: 762-774.
20. Iwasaki, H. and Akashi, K., Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007. 26: 726-740.
21. Gordon, S. and Taylor, P. R., Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005. 5: 953-964.
22. Imhof, B. A. and Aurrand-Lions, M., Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 2004. 4: 432-444.
23. Metcalf, D., The granulocyte-macrophage colony-stimulating factors. Science 1985. 229: 16-22.
24. Stanley, E. R., Guilbert, L. J., Tushinski, R. J. and Bartelmez, S. H., CSF-1-a mononuclear phagocyte lineage-specific hemopoietic growth factor. J. Cell. Biochem. 1983. 21: 151-159.
25. Burgess, A. W. and Metcalf, D., The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980. 56: 947-958.
26. Golde, D. W., Overview of myeloid growth factors. Semin. Hematol. 1990. 27: 1-7.
27. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rössner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 77-92.
28. Lesokhin, A. M., Hohl, T. M., Kitano, S., Cortez, C., Hirschhorn-Cymerman, D., Avogadri, F., Rizzuto, G. A. et al., Monocytic CCR2+ myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment. Cancer Res. 2012. 72: 876-886.
29. Umemura, N., Saio, M., Suwa, T., Kitoh, Y., Bai, J., Nonaka, K., Ouyang, G.-F. et al., Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J. Leukoc. Biol. 2008. 83: 1136-1144.
30. Murray, H. W., Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis. J. Immunol. 2005. 174: 4916-4923.
31. Li, Q., Eiden, L. E., Cavert, W., Reinhart, T. A., Rausch, D. M., Murray, E. A., Weihe, E. et al., Increased expression of nitric oxide synthase and dendritic injury in simian immunodeficiency virus encephalitis. J. Hum. Virol. 1999. 2: 139-145.
32. Pereira, W. F., Ribeiro-Gomes, F. L., Guillermo, L. V. C., Vellozo, N. S., Montalvao, F., DosReis, G. A. and Lopes, M. F., Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses. J. Leukoc. Biol. 2011. 90: 1191-1197.
33. Sprent, J., Lifespans of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 1993. 5: 433-438.
34. Nacy, C. A., Fortier, A. H., Meltzer, M. S., Buchmeier, N. A. and Schreiber, R. D., Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines. J. Immunol. 1985. 135: 3505-3511.
35. Mosser, D. M., Vlassara, H., Edelson, P. J. and Cerami, A., Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J. Exp. Med. 1987. 165: 140-145.
36. Bogdan, C. and Röllinghoff, M., How do protozoan parasites survive inside macrophages? Parasitol. Today 1999. 15: 22-28.
37. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 5791-5802.
38. Movahedi, K., Guilliams, M., van den Bossche, J., van den Bergh, R., Gysemans, C., Beschin, A., Baetselier, P. et al., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4244.
39. Nagaraj, S., Nelson, A., Youn, J. I., Cheng, P., Quiceno, D. and Gabrilovich, D. I., Antigen-specific CD4+ T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res. 2012. 72: 928-938.
40. Brewig, N., Kissenpfennig, A., Malissen, B., Veit, A., Bickert, T., Fleischer, B., Mostbock, S. et al., Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J. Immunol. 2009. 182: 774-783.
41. Sinha, P., Clements, V. K. and Ostrand-Rosenberg, S., Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 2005. 174: 636-645.
42. Stenger, S., Thüring, H., Röllinghoff, M. and Bogdan, C., Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 1994. 180: 783-793.
43. Ribechini, E., Leenen, P. J. and Lutz, M. B., Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells. Eur. J. Immunol. 2009. 39: 3538-3551.
44. Ma, C., Kapanadze, T., Gamrekelashvili, J., Manns, M. P., Korangy, F. and Greten, T. F., Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 2012. 92: 1199-1206.
45. Ritter, U., Meissner, A., Scheidig, C. and Korner, H., CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol. 2004. 34: 1542-1550.
46. Locksley, R. M., Heinzel, F. P., Sadick, M. D., Holaday, B. J. and Gardner, K. D., Jr., Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur Immunol. 1987. 138: 744-749.
47. Ritter, U. and Körner, H., Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunol. 2002. 24: 295-301.
48. Ritter, U., Moll, H., Laskay, T., Brocker, E., Velazco, O., Becker, I. and Gillitzer, R., Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J. Infect. Dis. 1996. 173: 699-709.
49. Balaña-Fouce, R., Calvo-Álvarez, E., Álvarez-Velilla, R., Prada, C. F., Pérez-Pertejo, Y. and Reguera, R. M., Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis. Mol. Biochem. Parasitol. 2012. 181: 85-93.
50. Iniesta, V., Carcelén, J., Molano, I., Peixoto, P. M. V., Redondo, E., Parra, P., Mangas, M. et al., Arginase I induction during Leishmania major infection mediates the development of disease. Infect. Immun. 2005. 73: 6085-6090.
51. Colotti, G. and Ilari, A., Polyamine metabolism in Leishmania: from arginine to trypanothione. Amino Acids 2011. 40: 269-285.
52. Munder, M., Choi, B.-S., Rogers, M. and Kropf, P., L-arginine deprivation impairs Leishmania major-specific T-cell responses. Eur. J. Immunol. 2009. 39: 2161-2172.
53. Bronte, V. and Zanovello, P., Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005. 5: 641-654.
54. Modolell, M., Corraliza, I. M., Link, F., Soler, G. and Eichmann, K., Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 1995. 25: 1101-1104.
55. Solbach, W., Forberg, K. and Röllinghoff, M., Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice. Infect. Immun. 1986. 54: 909-912.
56. Wilhelm, P., Ritter, U., Labbow, S., Donhauser, N., Röllinghoff, M., Bogdan, C. and Körner, H., Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 2001. 166: 4012-4019.
57. Rossner, S., Voigtlander, C., Wiethe, C., Hanig, J., Seifarth, C. and Lutz, M. B., Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 2005. 35: 3533-3544.
58. Bogdan, C., Thüring, H., Dlaska, M., Röllinghoff, M. and Weiss, G., Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J. Immunol. 1997. 159: 4506-4513.
59. Steiner, G. E., Ecker, R. C., Kramer, G., Stockenhuber, F. and Marberger, M. J., Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue. J. Immunol. Methods 2000. 237: 39-50.